CC Chemokine Receptor 2 (CCR2) antagonists enhance the generation of CD8+ T cells by suppressing the immunosuppressive effect of TAMs in HCC (Yao et al., 2017). This evidence concerns the gene CD8A and hepatocellular carcinoma.